Cdk inhibitors: on the threshold of checkpoints and development

Current Opinion in Cell Biology

Volumn 6, Issue 6, 1994, Pages 847-852

  Elledge, Stephen J ^a   Harper, J Wade ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; GROWTH FACTOR; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN P16; PROTEIN P21; PROTEIN P27;

CANCER INHIBITION; CELL CYCLE; CELL CYCLE S PHASE; CELL PROLIFERATION; ENZYME INHIBITION; ENZYME REGULATION; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; YEAST;

EID: 0028075611     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-0674(94)90055-8     Document Type: Article

References (56)

1. Cdc-2 activation: the interplay of cyclin binding and Thr161 phosphorylation
2. Control of the yeast cell cycle by the Cdc28 protein kinase
3. Activation of the various cyclin/cdc2 protein kinases
4. 1 cyclins
5. Cyclins and Cancer
6. Cyclins and cyclin-dependent kinases: take your partners
7. Creative blocks: cell-cycle checkpoints and feedback controls
8. Exercising self-restraint: discouraging illicit acts of S and M in eukaryotes
9. Checkpoint controls that couple mitosis to completion of DNA replication
10. Braking the cycle
11. Dams and sluices
12. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle.
13. Dual regulation of the CDC28-p40 protein kinase complex: cell cycle, phermone, and nutrient limitation effects
14. An inhibitor of p34CDC28 protein kinase activity from Saccharomyces cerevisiae
15. An inhibitor of yeast cyclin-dependent kinase plays an important role ensuring the genomic integrity of daughter cells
16. 1 transition in S. cerevisiae
17. 1/S transition in Saccharomyces cerevisiae
18. 1 cyclin, CLN2
19. Phosphorylation of FAR1 in response to α-factor: a possible requirement for cell cycle arrest
20. FAR1 links the signal transduction pathway to the cell cycle machinery in yeast
21. Direct inhibition of the yeast cyclin-dependent kinase Cdc28-Cln by Far1
22. Negative regulation of FAR1 at the Start of the yeast cell cycle
23. + gene
24. cdc2 in establishing the dependency of S phase on mitosis
25. 1 cyclin-dependent kinases
26. p21 is a universal inhibitor of cyclin kinases
27. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
28. WAF1, a potential mediator of p53 tumor suppression
29. Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression Screen
30. D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA
31. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.
32. 1 arrest and apoptosis
33. Defects in cell cycle checkpoints may be responsible for the genomic instability in cancer cells
34. p53 function and dysfunction
35. 1 arrest
36. Induction of WAF1/CIP1 by a p53-independent pathway
37. p53: at the crossroads of molecular carcinogenesis and risk assessment
38. p53: a glimpse at the puppet behind the shadow play
39. X-rays strike p53 again
40. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
41. Cdk-interacting protein-1 (Cip1, Waf1) directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase δ goloenzyme
42. 1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β
43. p27kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
44. Cloning of p27K1P1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals
45. 1 cyclin-Cdk protein kinase activity, is related to p21
46. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes
47. Cdk4 modulation by TGF-β leads to cell cycle arrest
48. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4
49. A cell cycle regulatory potentially involved in the genesis of many tumor types
50. Delection of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
51. Rates of p16 (MTS1) mutations in primary tumors with p9 loss
52. p16 gene in uncultured tumours
53. INK48 is a potential effector of TGFβ-induced cell cycle arrest
54. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
55. Germline p16 mutations in familial melanoma
56. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus